Worldquant Millennium Advisors LLC boosted its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 60.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,277,841 shares of the company's stock after acquiring an additional 482,741 shares during the quarter. Colgate-Palmolive comprises about 0.8% of Worldquant Millennium Advisors LLC's holdings, making the stock its 23rd largest holding. Worldquant Millennium Advisors LLC owned approximately 0.16% of Colgate-Palmolive worth $116,169,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive in the fourth quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Wintrust Investments LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 80.41% of the company's stock.
Wall Street Analysts Forecast Growth
CL has been the topic of several research reports. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research note on Monday, February 3rd. JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research note on Monday, April 28th. Piper Sandler cut their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. Raymond James restated an "outperform" rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Citigroup upped their price objective on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $102.12.
Read Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Performance
CL traded up $1.77 during trading hours on Friday, hitting $92.67. The company's stock had a trading volume of 6,723,726 shares, compared to its average volume of 4,677,772. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $75.10 billion, a PE ratio of 26.33, a PEG ratio of 4.20 and a beta of 0.39. The company has a 50-day simple moving average of $91.81 and a 200 day simple moving average of $91.24.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm's quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the company posted $0.86 EPS. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.
Colgate-Palmolive Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were paid a dividend of $0.52 per share. The ex-dividend date was Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.76%.
Colgate-Palmolive announced that its board has authorized a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's leadership believes its stock is undervalued.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.